These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28779373)

  • 21. Cell-based therapeutic strategies for multiple sclerosis.
    Scolding NJ; Pasquini M; Reingold SC; Cohen JA; ; ;
    Brain; 2017 Nov; 140(11):2776-2796. PubMed ID: 29053779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical lessons learned from the use of therapeutic plasma exchange in neurologic disease.
    McQuillen MP
    Ther Apher; 2000 Jun; 4(3):190-4. PubMed ID: 10910017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Editorial: multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S111. PubMed ID: 19361674
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethical issues concerning a pay-to-participate stem cell study.
    Turner L; Snyder J
    Stem Cells Transl Med; 2021 Jun; 10(6):815-819. PubMed ID: 34010517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early multiple sclerosis therapy in the effects of public health economics].
    Rieckmann P
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():17-21. PubMed ID: 11603111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards medicine of excellence in Mexico: the "Código Infarto" protocol, a view from the perspective of translational bioethics.
    Borrayo-Sánchez G; Flores-Morales A; Salas-Collado L; Altamirano-Bustamante MM
    Gac Med Mex; 2020; 156(5):366-372. PubMed ID: 33372921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells in multiple sclerosis - translation to clinical trials.
    Dulamea A
    J Med Life; 2015; 8(1):24-7. PubMed ID: 25914733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How are PCORI-funded researchers engaging patients in research and what are the ethical implications?
    Ellis LE; Kass NE
    AJOB Empir Bioeth; 2017; 8(1):1-10. PubMed ID: 28949867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who can say yes (or no) to a physician--and how does the physician know they can?
    McQuillen MP; Tariot P
    Neurology; 2005 May; 64(9):1494-5. PubMed ID: 15883305
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of the Knowledge Translation Research Network's grants program in cancer knowledge translation.
    O'Brien MA; Grunfeld E
    Curr Oncol; 2019 Aug; 26(4):270-271. PubMed ID: 31548807
    [No Abstract]   [Full Text] [Related]  

  • 31. Finding the right balance with participation in exercise and sport for individuals with multiple sclerosis: protocol for a pre and post intervention feasibility study.
    Smith M; Williams G; Barker R
    BMJ Open; 2020 Mar; 10(3):e035378. PubMed ID: 32193273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value-engineered translation for regenerative medicine: meeting the needs of health systems.
    Bubela T; McCabe C
    Stem Cells Dev; 2013 Dec; 22 Suppl 1(Suppl 1):89-93. PubMed ID: 24304083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lost in translation: can we afford to miss the trees for the forest?
    Hammes SR; Lange CA
    Horm Cancer; 2014 Aug; 5(4):203-6. PubMed ID: 24980775
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethical considerations in oncology: balancing the interests of patients, oncologists, and society.
    Smith TJ; Bodurtha JN
    J Clin Oncol; 1995 Sep; 13(9):2464-70. PubMed ID: 7666106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical aspects of unproved therapies in multiple sclerosis, amyotrophic lateral sclerosis, and other neurologic diseases.
    van den Noort S
    Semin Neurol; 1984 Mar; 4(1):83-6. PubMed ID: 11649670
    [No Abstract]   [Full Text] [Related]  

  • 36. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group.
    Rieckmann P; Boyko A; Centonze D; Elovaara I; Giovannoni G; Havrdová E; Hommes O; Kesselring J; Kobelt G; Langdon D; LeLorier J; Morrow SA; Oreja-Guevara C; Schippling S; Thalheim C; Thompson H; Vermersch P
    Mult Scler Relat Disord; 2015 May; 4(3):202-18. PubMed ID: 26008937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational nanomedicine: status assessment and opportunities.
    Murday JS; Siegel RW; Stein J; Wright JF
    Nanomedicine; 2009 Sep; 5(3):251-73. PubMed ID: 19540359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Featured Article: Serum [Met
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2017 Sep; 242(15):1524-1533. PubMed ID: 28766982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon beta treatment for multiple sclerosis.
    Forbes RB; Swingler RJ
    Lancet; 1999 Feb; 353(9151):496-8. PubMed ID: 9989743
    [No Abstract]   [Full Text] [Related]  

  • 40. Reproductive issues in women with multiple sclerosis: ethical considerations.
    Morgan-Followell BN; Nicholas JA; Weisleder P
    Continuum (Minneap Minn); 2014 Feb; 20(1 Neurology of Pregnancy):177-80. PubMed ID: 24492818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.